Glenmede Trust’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
$17.1M Sell
154,827
-8,529
-5% -$943K 0.09% 206
2024
Q4
$22.3M Buy
163,356
+153,095
+1,492% +$20.9M 0.11% 169
2024
Q3
$1.18M Sell
10,261
-828
-7% -$95.4K 0.01% 676
2024
Q2
$1.53M Sell
11,089
-1,862
-14% -$256K 0.01% 612
2024
Q1
$1.79M Sell
12,951
-202
-2% -$27.9K 0.01% 593
2023
Q4
$1.73M Buy
13,153
+10,127
+335% +$1.33M 0.01% 577
2023
Q3
$340K Sell
3,026
-6,238
-67% -$702K ﹤0.01% 951
2023
Q2
$938K Hold
9,264
0.01% 673
2023
Q1
$938K Sell
9,264
-7,559
-45% -$765K 0.01% 675
2022
Q4
$2.01M Buy
16,823
+6,525
+63% +$779K 0.01% 519
2022
Q3
$1.09M Sell
10,298
-4,765
-32% -$506K 0.01% 632
2022
Q2
$1.47M Sell
15,063
-1,750
-10% -$171K 0.01% 584
2022
Q1
$1.58M Sell
16,813
-4,800
-22% -$450K 0.01% 597
2021
Q4
$1.84M Sell
21,613
-10,269
-32% -$874K 0.01% 591
2021
Q3
$3.06M Sell
31,882
-3,451
-10% -$331K 0.02% 471
2021
Q2
$3.44M Sell
35,333
-529
-1% -$51.5K 0.02% 447
2021
Q1
$3.49M Sell
35,862
-4,734
-12% -$460K 0.02% 441
2020
Q4
$3.89M Buy
40,596
+17,363
+75% +$1.66M 0.02% 426
2020
Q3
$2.23M Sell
23,233
-3,000
-11% -$288K 0.01% 479
2020
Q2
$3.2M Buy
26,233
+6,971
+36% +$850K 0.02% 428
2020
Q1
$2.07M Hold
19,262
0.01% 619
2019
Q4
$2.07M Buy
19,262
+1,066
+6% +$115K 0.01% 619
2019
Q3
$1.64K Buy
18,196
+8,884
+95% +$800 0.01% 649
2019
Q2
$786 Sell
9,312
-10
-0.1% -$1 ﹤0.01% 802
2019
Q1
$821 Sell
9,322
-10
-0.1% -$1 ﹤0.01% 782
2018
Q4
$666 Buy
9,332
+112
+1% +$8 ﹤0.01% 801
2018
Q3
$1.13M Sell
9,220
-8
-0.1% -$983 ﹤0.01% 733
2018
Q2
$907K Sell
9,228
-1,280
-12% -$126K ﹤0.01% 726
2018
Q1
$815K Hold
10,508
﹤0.01% 816
2017
Q4
$815K Hold
10,508
﹤0.01% 816
2017
Q3
$643K Buy
10,508
+9,908
+1,651% +$606K ﹤0.01% 854
2017
Q2
$25K Hold
600
﹤0.01% 1847
2017
Q1
$25K Buy
+600
New +$25K ﹤0.01% 1847
2016
Q3
Sell
-41
Closed -$1K 2645
2016
Q2
$1K Hold
41
﹤0.01% 2475
2016
Q1
$1K Sell
41
-79
-66% -$1.93K ﹤0.01% 2517
2015
Q4
$6K Buy
+120
New +$6K ﹤0.01% 2216